Back to Search
PRAMOD MULTANI, MD
MD
Cardiovascular Disease Physician
NPI: 1407968746IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
A38056(CA)
Education
OTHER
Class of 1978
Research & Publications (16)
Development of radioimmunotherapy for the treatment of non-Hodgkin's lymphoma.
PMID 12512834·Int J Hematol·2002
6-review
Report of the fifteenth international symposium of the foundation for promotion of cancer research: new horizons in the diagnosis and treatment of hematological malignancies based on molecular genetic features.
PMID 12417606·Jpn J Clin Oncol·2002
8-other
Non-Hodgkin's lymphoma: review of conventional treatments.
PMID 11762410·Curr Pharm Biotechnol·2001
6-review
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.
PMID 19108889·Leuk Res·2009
3-trial
Leukemic blast and natural killer cell P-glycoprotein function and inhibition in a clinical trial of zosuquidar infusion in acute myeloid leukemia.
PMID 18976810·Leuk Res·2009
3-trial
Radioimmunotherapy of non-Hodgkin's lymphoma: clinical development of the Zevalin regimen.
PMID 15504711·Biotechnol Annu Rev·2004
6-review
Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-hodgkin's lymphoma.
PMID 12663713·J Clin Oncol·2003
8-other
Secondary acute myelogenous leukemia with MLL gene rearrangement following radioimmunotherapy (RAIT) for non-Hodgkin's lymphoma.
PMID 12539741·Leuk Lymphoma·2002
5-case
Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma.
PMID 12149300·J Clin Oncol·2002
3-trial
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial.
PMID 12036859·Blood·2002
3-trial
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
PMID 12011122·J Clin Oncol·2002
3-trial
Monoclonal antibodies: a new era in the treatment of non-Hodgkin's lymphoma.
PMID 11762412·Curr Pharm Biotechnol·2001
6-review
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
PMID 10905768·Biol Blood Marrow Transplant·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8333 IOWA ST STE 200
DOWNEY, CA 90241 - Phone
- (562) 923-1211
Quick Facts
- NPI
- 1407968746
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 48
- Publications
- 16
Are you this provider?
Claim Your Profile